Charles River Laboratorie(CRL.US)

Last Updated 19:00:00 ET
longbridge loading

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

MarketWatch Automated·
US
CRL
+2.53%
US
BBH
+0.68%
US
ARKG
+4.20%
MarketWatch Automated·
US
CRL
+2.53%
US
BBH
+0.68%
US
ARKG
+4.20%

A Look At Charles River Laboratories (CRL) Valuation After Recent Share Price Weakness

Simplywall·
US
CRL
+2.53%
US
IHF
-0.33%
US
ARKG
+4.20%
Simplywall·
US
CRL
+2.53%
US
IHF
-0.33%
US
ARKG
+4.20%

Charles River Laboratories International Inc. Stock Underperforms Thursday When Compared To Competitors

MarketWatch Automated·
US
CRL
+2.53%
US
LABU
+10.12%
US
IBBQ
+2.21%
MarketWatch Automated·
US
CRL
+2.53%
US
LABU
+10.12%
US
IBBQ
+2.21%

Charles River Laboratories International Inc. Stock Underperforms Wednesday When Compared To Competitors

MarketWatch Automated·
US
CRL
+2.53%
MarketWatch Automated·
US
CRL
+2.53%

Charles River Laboratories, Medipost Sign MoU on GMP-Compliant Testing

Fidelity·
US
CRL
+2.53%
US
XLV
-0.30%
US
LABD
-10.37%
Fidelity·
US
CRL
+2.53%
US
XLV
-0.30%
US
LABD
-10.37%

Charles River Laboratories International Inc. Stock Underperforms Monday When Compared To Competitors

MarketWatch Automated·
US
CRL
+2.53%
US
IBB
+1.75%
US
FBT
+1.61%
MarketWatch Automated·
US
CRL
+2.53%
US
IBB
+1.75%
US
FBT
+1.61%

Charles River Labs: Buy Rating Reiterated as 2026 Outlook Strengthens; $235 Price Target Maintained

Tip Ranks·
US
CRL
+2.53%
US
IBB
+1.75%
US
IDNA
+3.07%
Tip Ranks·
US
CRL
+2.53%
US
IBB
+1.75%
US
IDNA
+3.07%

Charles River Laboratories International (NYSE:CRL) Issues Earnings Results

Market Beat·
US
CRL
+2.53%
US
FBT
+1.61%
US
BBH
+0.68%
Market Beat·
US
CRL
+2.53%
US
FBT
+1.61%
US
BBH
+0.68%
© 2026 Longbridge｜Disclaimer